Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shaodong Hong"'
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Detailed individual characteristics of each patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::311a727887dc183eac39aaced267124b
https://doi.org/10.1158/1078-0432.22472763.v1
https://doi.org/10.1158/1078-0432.22472763.v1
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Individual gene mutations correlate with immunotherapy response in both Rizvi et al and our data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c5bfce3525f198d3a28c03088b6196
https://doi.org/10.1158/1078-0432.22472760.v1
https://doi.org/10.1158/1078-0432.22472760.v1
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Impact of copy number loss in genes in immune-related pathways on immunotherapy response in Miao et al and our data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eca42c830b4ae57dbc55ecd1f26224a8
https://doi.org/10.1158/1078-0432.22472748
https://doi.org/10.1158/1078-0432.22472748
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Supplementary Figures S1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::762a1b76bffeca274b2daf2192149a06
https://doi.org/10.1158/1078-0432.22472766.v1
https://doi.org/10.1158/1078-0432.22472766.v1
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Purpose:Immune checkpoint inhibitors (ICI) have revolutionized cancer management. However, molecular determinants of response to ICIs remain incompletely understood.Experimental Design:We performed genomic profiling of 78 patients with non–small ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e005f87971ab2a07cbe0edbf901f11
https://doi.org/10.1158/1078-0432.c.6528318.v1
https://doi.org/10.1158/1078-0432.c.6528318.v1
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Copy number alterations correlate with immunotherapy response in both Miao et al and our data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077cf2441190dbfafdc1a774b0b2217d
https://doi.org/10.1158/1078-0432.22472754
https://doi.org/10.1158/1078-0432.22472754
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Influence of histology on survival analyses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cdf6b876d354c796da0bd8c7c3cc404
https://doi.org/10.1158/1078-0432.22472757
https://doi.org/10.1158/1078-0432.22472757
Autor:
Li Zhang, Yang W. Shao, Hongyun Zhao, Yan Huang, Yunpeng Yang, Xue Wu, Hua Bao, Fufeng Wang, Ao Wang, Huaqiang Zhou, Shaodong Hong, Jiani C. Yin, Yuxiang Ma, Wenfeng Fang
Copy number alterations in genes in immune-related pathways in each patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e186d5e88be1b1dfb1a1ddaa1cd356
https://doi.org/10.1158/1078-0432.22472751.v1
https://doi.org/10.1158/1078-0432.22472751.v1
Autor:
Li-na He, Xuanye Zhang, Xinze Lv, Yuxi Zhou, Min Li, Ting Hou, Wenjie Sun, Li Zhang, ShaoDong Hong
Publikováno v:
Cancer Research. 82:5762-5762
Introduction: Pulmonary lymphoepithelioma-like carcinoma (PLELC) is a rare and distinct subtype of non-small cell lung cancer (NSCLC). The use of immune checkpoint inhibitors (ICIs) for advanced PLELC and tumor genomic features underlying varied trea
Autor:
Wenfeng Fang, Yunpeng Yang, Li Mao, Giovanni Selvaggi, Jing Zhao, Yan Huang, Hongyun Zhao, Yuxiang Ma, Shaodong Hong, Jianjin Huang, Li Zhang, Lieming Ding, Yang Zhang
Publikováno v:
Cancer Research. 80:579-579
Background: Ensartinib (X-396) is a novel ALK inhibitor with high activity against a broad range of crizotinib-resistant ALK mutations (such as G1269A, F1174, C1156Y, and T1151) and CNS metastases. This Phase I study (NCT02959619) determined the maxi